Health care industry
Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro
The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, on Sept. 17, 2020. Mike Blake | Reuters Eli Lilly is suing two pharmacies for compounding Zepbound and Mounjaro, claiming the companies are skirting the Food and Drug Administration’s ban on the practice and luring people away from Lilly’s […]
Read More
Layoffs begin at U.S. health agencies charged with tracking disease, and researching and regulating food
Employees across the massive U.S. Department of Health and Human Services began receiving notices of dismissal on Tuesday in a major overhaul expected to ultimately lay off up to 10,000 people. The notices come just days after President Donald Trump moved to strip workers of their collective bargaining rights at HHS and other agencies throughout […]
Read More
‘Peak’ uncertainty: Evercore ISI predicts market turning point around Trump tariffs
Fast Money ‘Peak’ uncertainty: Evercore ISI predicts market turning point around Trump tariffs Published Mon, Mar 31 20256:54 PM EDT Stephanie Landsman@stephlandsman WATCH LIVE Source
Read More
Don’t overlook the impact of pharma tariffs, says an analyst. Where we stand on Bristol Myers
The drug stock is higher over the past month while the S&P 500 has pulled back sharply. Source
Read More
Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.
Rafael Henrique | Lightrocket | Getty Images Shares of major vaccine makers dropped on Monday after a key U.S. health official resigned in protest of Health and Human Services Secretary Robert F. Kennedy Jr.’s views on immunization. The departure of Peter Marks, the Food and Drug Administration’s top vaccine regulator, has raised fresh fears about […]
Read More
23andMe bankruptcy: With America’s DNA put on sale, market panic gets a new form of testing
Signage at 23andMe headquarters in Sunnyvale, California, U.S., on Wednesday, Jan. 27, 2021. David Paul Morris | Bloomberg | Getty Images DNA testing has become a valuable tool for hobbyists and novice genealogists. For some, learning they are the 10th cousin of Paul Revere or the 15th great nephew four times removed of the last […]
Read More
Novo Nordisk’s diabetes pill slashes risk of cardiovascular complications by 14% after four years
Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with diabetes and heart disease. The pill lowered the risk of cardiovascular-related death, heart attack and stroke by 14% compared to a placebo after four […]
Read More
New blood pressure drug helps people with uncontrolled hypertension in trial
A new type of medication may help lower blood pressure in people with uncontrolled hypertension, researchers reported Saturday at the annual meeting of American College of Cardiology in Chicago. In a pivotal Phase 2b clinical trial, patients who took the experimental medication lorundrostat along with two or three currently available hypertension drugs saw a decrease in systolic […]
Read More
Top FDA vaccine official Peter Marks resigns in opposition to RFK Jr.
Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration answers a question during a Senate Health, Education, Labor and Pensions Committee hearing to discuss the on-going federal response to COVID-19, at the U.S. Capitol in Washington, D.C., May 11, 2021. Greg Nash | Pool | Reuters […]
Read More
We’re buying more shares of 2 stocks as the broader market sinks further
We’re making our first trades of the week. We are buying 25 shares of Danaher at roughly $207 each. Following Friday’s trade, Jim Cramer’s Charitable Trust will own 550 shares of DHR, increasing its weighting to 3.5% from 3.35%. We are buying 10 shares of Home Depot at roughly $358. Following the trade, the Trust […]
Read More